|
|
||||||||
Eur J Cardiothorac Surg 2004;25:865-871
© 2004 Elsevier Science NL
a Division of Thoracic Surgery, University Hospital, Zurich, Switzerland
b Department of Pathology, University Hospital, Zurich, Switzerland
Received 10 October 2003; received in revised form 7 January 2004; accepted 12 January 2004.
* Corresponding author. Tel.: +41-12-55-8802; fax: +41-12-55-8805
e-mail: didier.lardinois{at}usz.ch
| Abstract |
|---|
|
|
|---|
Key Words: Non-steroidal anti-inflammatory drug Mechanical pleural abrasion Pleurodesis Collagen deposition Pig model
| 1. Introduction |
|---|
|
|
|---|
Video-assisted thoracoscopic surgery (VATS) has been demonstrated to be a safe and reliable method in the management of recurrent spontaneous pneumothorax [69]. Thoracoscopic wedge-resection of an identified bleb combined with mechanical pleurodesis or apical pleurectomy is mostly considered as the standard therapy of recurrent pneumothorax. However, in patients who underwent mechanical pleural abrasion, a recurrence rate between 3 and 10% has been reported in different series, often within 1 year postoperatively [10,11]. Reduction of the recurrence rate could be obtained by training surgeons not to overlook blebs during the procedure, consider widening the area of pleurodesis, and/or perform apical pleurectomy [12,13]. The objective of the present study was to assess if NSAIDs affect the quality of pleurodesis resulting from mechanical abrasion in pigs. We hypothesized that the current use of NSAIDs perioperatively in patients with spontaneous pneumothorax could influence the rate of recurrence of the disease after thoracoscopic therapy, due to a decrease in the quality of adhesions obtained after mechanical pleural abrasion.
| 2. Materials and methods |
|---|
|
|
|---|
2.2. General design
Ten VLS (Schweizerisches Veredeltes Landschwein) pigs with a mean weight of 41.3 kg (range 37.944.7 kg) were randomly divided into one treatment group and one control group of five animals each. A unilateral left thoracoscopy and an apical pleural abrasion by use of a commercially available abrader (electro-surgical tip cleaner, Surgisite®, Johnson & Johnson) were performed in all animals. A chest tube was placed until the animals were extubated. The animals were then extubated. In the treatment group, an NSAID (diclofenac-Voltaren®) was orally given to the animals at a dosage of 100 mg daily for 3 weeks after surgery. The animals were then sacrificed. At autopsy, the efficacy of pleurodesis was graded by evaluating the gross appearance of each pleural cavity and lung (pleurodesis score), by determining the extent of adhesion formation (obliteration grade), and by histologic examination. Macroscopic and microscopic evaluations were performed by three reviewers, respectively, two pathologists, blinded to the treatment.
2.3. Operative technique
Premedication was performed by use of ketamin 1020 mg/kg+azaperon 2 mg/kg+atropine 0.020.05 mg/kg intramuscularly. The animals underwent standard endotracheal intubation (endotracheal tubes AIRE-CUF, with connector, Provet AG). Inhalation anesthesia consisted of O2 and Isofluran. Perioperative monitoring consisted of measurements of arterial blood pressure by use of a cuff and online registration of ECG, temperature, and pulsoxymeter. A venous catheter for infusions was introduced through a vein on the ear. All animals received amoxycillin as an antibiotic therapy (1020 mg/kg intramuscular) before the operation.
An anti-microbial skin preparation (povidoneiodine) was employed prior to all invasive procedures, each of which was performed by aseptic surgical technique. For thoracoscopic pleurodesis, three 10 mm-trocars were introduced (the optic trocar in the ninth intercostal space, the two others in the eighth intercostal space, anteriorly and posteriorly). Surgery was performed on the left side. Visual examination of the left hemithorax was performed using a rigid telescope and video camera (Richard Wolf Co). Thoracoscopic mechanical abrasion was then performed by rubbing the parietal pleura with an abrader (electro-surgical tip cleaner, Surgisite®, Johnson & Johnson) until punctate hemorrhages were observed and localized areas of the pleura were abraded (Fig. 1a and b) . At the conclusion of each thoracoscopic procedure, a chest tube was inserted through one of the trocar insertion sites. The pleural drain was connected to a reservoir and negative suction (20 cmH2O) was applied. The cutaneous trocar incisions were closed with running silk. The chest tube was removed as soon as the animals were awake and began moving, and radiographic verification of complete lung re-expansion was then performed. Directly postoperatively, 1 ml buprenorphine (Temgesic®) at a dosage of 0.3 mg/ml was administrated subcutaneously to all animals to suppress immediate postoperative pain. A patch of fentanyl (Durogesic TTS 75 µg/h®) was also applied on the skin of all animals during the first 3 days postoperatively. No animal of the control group required additional pain therapy from the 4th day until sacrifice. The other animals received diclofenac (Voltaren®) orally at a dosage of 100 mg daily for 3 weeks.
|
A five-point pleurodesis-score was employed to characterize the response to pleurodesis:
The extent of pleurodesis within the pleural cavity was assessed by use of an obliteration grade, measuring the distribution of adhesions between lung and chest wall in the four locations, apical, mediastinal, lateral, and dorsal
2.5. Microscopic evaluation
In the areas of greatest adhesion formation, a 23 cm wedge of lung parenchyma was removed en bloc with a corresponding portion of the chest wall. A specimen was placed in 10% neutral buffered formaldehyde solution and labeled for subsequent identification. Paraffin sections were stained with hematoxylineosin and elastin-van Gieson stains. The review of the specimens was made by two pathologists who were blinded to the treatment of the animals. The extent of fibrosis, production of collagen, granulation tissue formation, and foreign body granulomas were assessed. A four-point fibrosis-score was used to evaluate the collagen deposition between the lung and the chest wall
2.6. Statistical analysis
The data were expressed as median±SD. A non-parametric analysis of variance (MannWhitney test, SPSS for Windows, Version 11.0) was performed. A P-value <0.05 was considered statistically significant.
| 3. Results |
|---|
|
|
|---|
In all animals, chest X-ray showed a fully re-expanded left lung after removal of the chest tube.
Observation of the right, non-treated thoracic cavity showed no preexisting adhesions in all animals at autopsy.
Gross macroscopic evaluation showed a more effective pleurodesis, with more dense adhesions requiring sharp dissection for lysis in the control animals with a median pleurodesis score of 3.67±1.0 in comparison to 2±2.2 in the treatment group (P=0.01*, MannWhitney non-parametric test). The distribution of the scores given by the three independent reviewers was homogeneous in all control animals (Table 1). In one treatment animal, the scores were comparable in all but one animal in which scattered adhesions were observed. This animal presented with postoperative diarrhea. Adhesion distribution was uniform and comparable with a median obliteration score of 3.67±1.3 in the two groups of animals.
|
|
|
| 4. Discussion |
|---|
|
|
|---|
Gross macroscopic analysis showed significantly more dense adhesions in the non-treated group. This observation was confirmed by the microscopic evaluation. The difference in the analysis of the fibrosis score was not statistically significant, although a clear trend was shown. This could be due to the small number of animals in each group and to the fact that an animal, which received diclofenac, showed adhesions and collagen deposition. This animal presented with diarrhea postoperatively, which could have impaired the resorption of the substance. In all the other animals, both pleurodesis and fibrosis scores were uniformly distributed.
The obliteration grade is a measure of the extent of adhesions between the lungs, mediastinum and chest wall. The fact that there was no score difference between the two groups as well as the homogeneous repartition of the obliteration grade within each group confirm the reproducibility of our thoracoscopic approach and of the technique of mechanical abrasion used and suggest that abrasion was similar in depth and surface area in all animals. In the microscopic evaluation, the degree of inflammation was comparable in both groups and not very marked. This was not surprising in the animals of the treatment group, since NSAIDs can markedly blunt the early inflammatory process consisting of migration of leukocytes, edema formation, production of fibrin and capillary dilation [3,4,25]. It was also demonstrated that besides the inhibition of the cyclooxygenase pathway, NSAIDs also act as immunomodulating agents by blocking the production of endogenous prostaglandin-E. Prostaglandin-E is involved in regulating monocyte production of collagenase as well as mediating inflammation, and collagenase plays an important role in the breakdown and remodeling of collagen.
In the control group, scar tissue had already developed between the visceral and the parietal pleura at the control time 3 weeks after mechanical abrasion. The inflammatory process after pleural abrasion, including an ingrowth of capillaries, an influx of inflammatory cells with activation of fibroblasts, could have been already achieved at this time. Fibrosis without significant inflammatory reaction was already described in a pig model 30 days after chemical or mechanical abrasion [18,21]. Our results and the data of these previous studies support the concept that adhesion strength and numbers is dependent on an initial and transient inflammatory reaction but not on a persistent chronic inflammation.
In our study, 100 mg diclofenac (Voltaren®) was administrated daily. This dosage is similar to the usual postoperative dosage in humans. Gastro-enterologic side-effects were not expected in this project, since NSAIDs have already been administrated to pigs over a long time without development of ulceration in other trials [3]. After co-administration of a selective blocker of the proton pump, postoperative recovery was uneventful in all animals. All the animals received the same dose of opiates, ruling out an hypothetic influence of these substances in the interpretation of the results.
In conclusion, the present study demonstrates that the use of classical NSAIDs significantly decreases the quality of pleurodesis after mechanical abrasion in this pig model. As a consequence, we have changed our clinical practice in the postoperative analgesic therapy of the patients receiving a mechanical pleurodesis either for a pneumothorax or for a malignant effusion. Furthermore, since we could demonstrate the negative effects of these drugs on the quality of pleurodesis, a continuation of this trial evaluating other NSAIDs like selective COX-II inhibitors and nitric oxide-releasing NSAIDs is on-going in the same animal model and using different techniques of pleurodesis like pleurectomy.
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
Do you think that you could come up with a feasible design to test this in the human situation?
This morning, in another session, there was talk about whether Society and the Association lead multicenter trials. Do you think this could be done in that way?
Dr Lardinois: Although the number of the animals was small in our study, the difference between the two groups was so clear and undoubtful that we have changed our clinical practice in the postoperative analgesic therapy of the patients receiving a mechanical pleurodesis either for a pneumothorax or for a malignant effusion. We do not give classical NSAIDs any more.
Dr J. Wihlm (Strasbourg, France): Actually, it's a concept we have, since years, in our department because we are fighting with the anesthesiologists because when they stopped any means of pain control including peridural analgesia, for example, they gave oral morphinics and these kinds of drugs. And we completely abandoned that especially when operating on emphysema and COPD people.
Dr Lardinois: We can understand the anesthesiologists when giving NSAIDs for postoperative pain management because these substances have potent analgesic effects without having side-effects on the central neural system and additionally due to the large number and varieties of these agents.
Dr G. Egri (Budapest, Hungary): I only wonder if you had any data before concerning this effect of NSAIDs, or how did you have this concept to look if these kinds of drugs have such effects on the pleura?
Dr Lardinois: Several reports already showed that NSAIDs can inhibit the inflammatory process and the formation of fibrosis, due to their ability to suppress prostaglandin synthesis. It was also demonstrated that collagen concentration at the wound site was less after use of NSAIDs than in the untreated wounds. Furthermore, the degree of mechanical or chemical pleurodesis has already been evaluated and compared in different trials in animals by use of several scores. Pigs represent an ideal animal model for this experimental project because this model has already been established in the evaluation of different surgical techniques of the spontaneous pneumothorax and in the comparison of different modalities of pleurodesis. To facilitate comparisons with other experimental studies, we intentionally used both the previously described pleurodesis score and obliteration grade to assess macroscopic outcome.
Dr S. Eggeling (Berlin, Germany): I have two questions. The first is do you think that you can transport this model to pleurectomy, so spontaneous pneumothorax operation with pleurectomy?
And the second one is, there are a lot of non-steroid anti-phlogistic drugs, and do you have an idea if this is true, for example, for Novalgin (Novaminsulfon)?
Let me tell you that for 5 or 6 years we abandoned any NSAIDs from pleurodesis because of this point of view. This is a very nice study, and it's good to know that you found out what we already thought that will be true; but we always used Novalgin, and we think that this doesn't reduce the effect of pleurodesis.
Dr Lardinois: Regarding the first question, I cannot give you a precise answer. In the literature it is not clear what represents the best technique of pleurodesis in patients. There are reports showing a benefit of talc pleurodesis and other demonstrating an advantage of mechanical pleurodesis or of pleurectomy. We choose the VATS approach combined with a mechanical abrasion because thoracoscopic wedge-resection of an identified bleb combined to mechanical pleurodesis is mostly considered as the standard therapy of recurrent pneumothorax. We are evaluating other analgesics like selective COX-2 inhibitors on the same model using mechanical or other modalities of pleurodesis in an ongoing study. Regarding your second question, we do not use Nivaquine in our institution and I have no experience with it.
Dr G. Ladas (London, UK): There is evidence we saw that a single dose of non-steroidals produces analgesic effect quite quickly, while the anti-inflammatory effect takes longer, takes a couple of weeks to become pronounced.
So the question is, how did you choose this 3-week period? Because what often happens, the most difficult period for postoperative pain control is when you stop the PCA or epidural. And some people feel that giving a single or a couple doses of non-steroidals may help you in this transition period without necessarily carrying over for 3 weeks. So do you plan to look into the effect in a shorter period of administration?
Dr Lardinois: As already mentioned, the degree of mechanical or chemical pleurodesis has already been evaluated and compared in different trials in animals. In these previous reports, macroscopic observation and assessment of samples for histologic analysis were usually performed 34 weeks after pleurodesis because at this time, the histopathologic changes were already present and the inflammatory process has been already achieved. Furthermore, we wanted to put the animals in an analogous situation to patients with pneumothorax, who often take analgesics for a few weeks after surgery. That is the reason why an observation at 3 weeks postoperative has been proposed in our study.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Pompeo, F. Tacconi, D. Mineo, and T. C. Mineo The role of awake video-assisted thoracoscopic surgery in spontaneous pneumothorax J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 786 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hunt, E. Teh, R. Southon, and T. Treasure Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 102 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bobbio, L. Ampollini, E. Internullo, D. Caporale, L. Cattelani, S. Bettati, P. Carbognani, and M. Rusca Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 6 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Teixeira, F. S. Vargas, M. M. P. Acencio, P. F. S. Paz, L. Antonangelo, M. A. C. Vaz, and E. Marchi Influence of Antiinflammatory Drugs (Methylprednisolone and Diclofenac Sodium) on Experimental Pleurodesis Induced by Silver Nitrate or Talc Chest, December 1, 2005; 128(6): 4041 - 4045. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |